Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Schiffman

Showing results (1-10 of 498) with videos related to

Pageof 50
Sort By:
Journal of Lower Genital Tract Disease|October 20, 2006
How should the first abnormal pap smear in an 83-year-old woman be managed? Response 4Mark Schiffman
Cancer|May 10, 2007
Integration of human papillomavirus vaccination, cytology, and human papillomavirus testingMark Schiffman
Preventive Medicine|June 7, 2017
In response to: Human papillomavirus screening for low and middle-income countriesMark Schiffman
Journal of Lower Genital Tract Disease|May 6, 2005
Evidence-based screening and management guidelines address the realistic concerns of practicing clinicians and pathologistsMark Schiffman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2011
The need for forward-looking decision analyses to guide cervical cancer preventionMark Schiffman
Journal of the National Cancer Institute|December 14, 2025
RE: An observational study of deep learning and automated evaluation of cervical images for cancer screeningMark Schiffman
Preventive Medicine|March 11, 2017
Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practiceMark Schiffman
Archives of Pathology & Laboratory Medicine|July 23, 2003
Findings to date from the ASCUS-LSIL Triage Study (ALTS)Mark Schiffman, Diane Solomon
The Lancet. Oncology|November 15, 2011
Success of HPV vaccination is now a matter of coverageMark Schiffman, Sholom Wacholder
Preventive Medicine|October 24, 2017
Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesionsMark Schiffman, Nicolas Wentzensen
Pageof 50

Showing results (1-10 of 498) with videos related to

Sort By:
Pageof 50
Journal of Lower Genital Tract Disease|October 20, 2006
How should the first abnormal pap smear in an 83-year-old woman be managed? Response 4Mark Schiffman
Cancer|May 10, 2007
Integration of human papillomavirus vaccination, cytology, and human papillomavirus testingMark Schiffman
Preventive Medicine|June 7, 2017
In response to: Human papillomavirus screening for low and middle-income countriesMark Schiffman
Journal of Lower Genital Tract Disease|May 6, 2005
Evidence-based screening and management guidelines address the realistic concerns of practicing clinicians and pathologistsMark Schiffman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2011
The need for forward-looking decision analyses to guide cervical cancer preventionMark Schiffman
Journal of the National Cancer Institute|December 14, 2025
RE: An observational study of deep learning and automated evaluation of cervical images for cancer screeningMark Schiffman
Preventive Medicine|March 11, 2017
Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practiceMark Schiffman
Archives of Pathology & Laboratory Medicine|July 23, 2003
Findings to date from the ASCUS-LSIL Triage Study (ALTS)Mark Schiffman, Diane Solomon
The Lancet. Oncology|November 15, 2011
Success of HPV vaccination is now a matter of coverageMark Schiffman, Sholom Wacholder
Preventive Medicine|October 24, 2017
Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesionsMark Schiffman, Nicolas Wentzensen
Pageof 50